Cost and clinical impact of a nonmedical DPP-4 inhibitor switch in patients with diabetes

BACKGROUND: Nonmedical formulary switches (NMFS) routinely occur in managed health care plans and involve changing preferred medications for reasons outside of clinical considerations. The cost implications of NMFS are infrequently published and the clinical outcomes rarely assessed. OBJECTIVE: To a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kheloussi, Steven, Johns, Alicia, Parente, Vincenzo, McLay, William, Gionfriddo, Michael R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390945/
https://www.ncbi.nlm.nih.gov/pubmed/34185559
http://dx.doi.org/10.18553/jmcp.2021.27.7.846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390945/
https://www.ncbi.nlm.nih.gov/pubmed/34185559
http://dx.doi.org/10.18553/jmcp.2021.27.7.846

Ejemplares similares